About AnnJi Pharmaceutical Co. Ltd
Dedicated to New Drug Development in Dermatology & Neurology
Founded in 2014, AnnJi Pharmaceutical Co., Ltd. (AnnJi) is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, or SBMA (Spinal and bulbar muscular atrophy).
Our mission is to develop innovative therapeutics to improve the quality of life of patients with neglected diseases. Our goals are to translate and develop unique, innovative, and highly differentiated drug therapies and to engage global collaborators and business partners in late-stage product development and commercialization.
Taiwan’s leading new drug developer in dermatology & neurology
Translation and development of new chemical entities from lead optimization, candidate selection to clinical proof-of-concept